newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Provides Update on Fetal Growth Restriction Key Opinion Leader Webinar

Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction now Scheduled for November 24, 2026 Event to Include Results from First Two Phase 2 Early-Onset FGR Trial Cohorts DiaMedica Therapeutics Inc.